Open AccessMetabolic syndrome as a clinical manifestation of endothelial dysfunction
Author(s) -
Л. Л. Кириченко,
К. В. Овсянников,
А. Н. Федосеев,
А. М. Шкляров,
А. П. Королев
Publication year - 2012
Publication title -
kardiovaskulârnaâ terapiâ i profilaktika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.158
H-Index - 16
eISSN - 2619-0125
pISSN - 1728-8800
DOI - 10.15829/1728-8800-2012-2-85-89
Subject(s) - endothelial dysfunction , pathological , medicine , metabolic syndrome , adverse effect , bioinformatics , intensive care medicine , obesity , biology
Metabolic syndrome (MS) has recently gained more clinical attention due to its increasing prevalence and association with adverse prognosis. One of the main pathological features of MS is endothelial dysfunction. It plays a key role in the development of cardiovascular MS complications. Therefore, effective therapy aimed at the normalization of endothelial function should be a part of pathogenetic management of MS patients.